Allogene Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALLO Nasdaq 2830 allogene.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allogene Therapeutics, Inc.

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update - Aug 4th, 2026 6:30 am
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma - Jul 29th, 2026 6:30 am
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors - Jul 15th, 2026 6:30 am
Kyverna Therapeutics Sinks 13%: Here’s Why - Jul 10th, 2026 1:59 pm
Allogene Therapeutics (ALLO) Stock Gets Fair Value Boost After Split Analyst Revisions - Jun 27th, 2026 11:05 pm
How Allogene Therapeutics (ALLO) Is Expanding Its Off-the-Shelf CAR T Platform Across Cancer and Autoimmune Disease - Jun 17th, 2026 9:17 am
Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report? - Jun 12th, 2026 9:30 am
Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio - Jun 7th, 2026 11:57 am
Allogene Therapeutics Announces Planned CEO Succession - May 28th, 2026 3:02 pm
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - May 26th, 2026 6:30 am
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1 - May 14th, 2026 8:17 am
Big Pharma’s 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders - May 14th, 2026 7:20 am
Allogene Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 14th, 2026 6:30 am
Allogene Therapeutics Inc (ALLO) Q1 2026 Earnings Call Highlights: Promising Trial Results and ... - May 13th, 2026 11:00 pm
Allogene Therapeutics Q1 Earnings Call Highlights - May 13th, 2026 6:13 pm